Crestline Management’s Sarepta Therapeutics SRPT Stock Holding History

Crestline Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$4.12M	Buy
2018 Q3	–	Sell
2018 Q2	$1.87M	Buy
2017 Q3	–	Sell
2017 Q2	$2.07M	Buy
2017 Q1	$965K	Buy